abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

24 Apr 2007

Author:
Novartis

Novartis delivers 4.7 million treatments of anti-malarial medicine to Tanzania on Africa Malaria Day

Novartis has delivered 4.7 million treatments of its life-saving anti-malaria medicine, Coartem, to the United Republic of Tanzania, an African country where malaria is the leading cause of death in both children and adults. This delivery is part of a larger global effort to provide access to Coartem without profit to patients living in malaria-endemic countries...The company urges governments, companies and other organizations to work together to broaden access and remove cultural or educational hindrances to treatment...